Table. Cases of laboratory-confirmed secondary and tertiary transmission of vaccinia virus from US military service member, New York, USA, 2010*.
| No.† | Transmission type | Age, y/sex | Exposure |
Illness |
Underlying risk factors | VIG | Duration of lesions, wk | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Date | Source | Type | Onset | Location of lesions | |||||||
| 1 | Secondary | 26/M | Feb 27 | Military vaccinee | Wrestling | Mar 1 | Face, neck, chest | None | No | ≈3 | |
| 2 | Secondary | 24/M | Feb 27 | Military vaccinee | Wrestling | ≈Mar 1 | Face, neck, chin, eye | None | No‡ | ≈3 | |
| 3 | Tertiary | 25/M | Mar 5 | Case-patient 1 | Wrestling | Mar 7 | Chest, trunk, arm | Mild eczema | No | ≈7 | |
| 4 | Tertiary | 29/F | After March | Case-patient 1 | Household | Mar 9 | Face, mandible, nostril | None | Yes | ≈3 | |
*VIG, varicella immune globulin. †Case-patient no. ‡Use of VIG not indicated; treated with trifluridine ophthalmic solution (3).